BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210615
DTEND;VALUE=DATE:20210618
DTSTAMP:20260515T190342
CREATED:20210212T080535Z
LAST-MODIFIED:20210212T080535Z
UID:28924-1623715200-1623974399@www.pharmajournalist.com
SUMMARY:2nd RNAi-Based Therapeutics – Digital Summit
DESCRIPTION:As investments and collaborations hit a record high\, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases\, exciting efforts have now turned to a wide range of other diseases\, from CNS\, oncology\, metabolism and more. Despite the growing momentum\, much needs to be addressed in terms of targeted delivery\, safety\, and efficiency to fully unleash the therapeutic value of RNAi drugs. \n \nBuilt with large pharma and pioneering biotech insights\, the 2nd RNAi- Based Therapeutics Summit returns virtually in 2021 to reunite key stakeholders of the field to tap into the full therapeutic opportunity of a wide-range of targeted RNAi therapies with enhanced endosomal escape\, extrahepatic delivery\, & PKPD for CNS\, oncology & beyond. \nWith a number of RNAi based clinical candidates emerging and excitement building in the field\, join the 2nd RNAi Based Therapeutic Summit 2021 – the comprehensive industry guide for senior biopharmaceutical leaders from discovery\, translation & clinical development functions to stay ahead of the race in developing the first targeted extrahepatic RNAi therapy that addresses unmet patient need. \nTo know more about 2nd RNAi-Based Therapeutics please click here.
URL:https://www.pharmajournalist.com/event/2nd-rnai-based-therapeutics-digital-summit/
LOCATION:Digital Event\, EDT
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210616
DTEND;VALUE=DATE:20210618
DTSTAMP:20260515T190342
CREATED:20201020T102522Z
LAST-MODIFIED:20201020T102824Z
UID:27546-1623801600-1623974399@www.pharmajournalist.com
SUMMARY:Skin Microbiome Summit
DESCRIPTION:Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products\, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment\, figuring out not only product development & formulation but also marketing strategy to raise more attention to this type of products. Despite huge popularity and early success stories\, there is still a need to learn more on topics such as: defining the skin microbiome\, formulating products\, cosmetics & pharma claims\, regulation for novel products\, latest advances in terms of mapping & profiling technologies\, as well as product testing. \n \nACI’s Skin Microbiome Industry Summit\, taking place on the 16th & 17th June 2021 in London\, will bring together the key actors of the industry to help the industry learn from one another\, work together to further grow and create new business opportunities. \nDuring the 2 days conference\, the participants will enjoy the various case studies presentations\, panel discussion\, Q&As and networking breaks to get the industry to thrive together. \nJoin us in London for a highly interactive & informative conference\, whilst enjoying the networking opportunities with your peers. \nMembers are entitled to a special discount on registration – to claim please contact Adamantia (Mado) Lampropoulou on MLampropoulou@acieu.net or +44 (0) 203 141 0607 quoting SSMe1MKTG.
URL:https://www.pharmajournalist.com/event/skin-microbiome-summit/
LOCATION:Park Plaza Westminster Bridge 200 Westminster Bridge Rd\, Bishop’s London\, SE1 7UT\, United Kingdom
ORGANIZER;CN="Active Communications International (ACI)":MAILTO:Mlampropoulou@acieu.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210617
DTEND;VALUE=DATE:20210619
DTSTAMP:20260515T190342
CREATED:20190131T121650Z
LAST-MODIFIED:20200608T143856Z
UID:19291-1623888000-1624060799@www.pharmajournalist.com
SUMMARY:Pharmaceutical Microbiology West Coast
DESCRIPTION:SMi’s 4th Pharmaceutical Microbiology West Coast Conference \nNovel approaches and best practices for tackling current industry contamination control challenges \nSMi’s 4th Annual Conference Pharmaceutical Microbiology West Coast\nNEW DATE: June 17 – 18\, 2021\nLocation: Hyatt Regency Mission Bay Hotel\, San Diego\, CA\, USA\nWebsite: http://www.pharma-microbiology-usa.com \n \nSPONSORED BY: Associates of Cape Cod\, bioMérieux\, Bioscience International\, Microcoat\, Millipore Sigma and Mettler Toledo \nCo-chairs Jim Polarine\, Senior Technical Service Manager\, STERIS Corporation & Geeta Singh\, Plant and Network Technical Specialist III\, Genentech \nFollowing on the success of the last West Coast event\, SMi proudly presents the 4th Pharmaceutical Microbiology West Coast Conference\, in San Diego\, USA\, on June 17th and 18th 2021 bringing microbiology experts to focus on innovations in rapid methods and contamination control strategies. Microbes such as bacteria\, fungi\, parasites and viruses that can contaminate current and novel pharmaceutical products or therapies may stem from various sources such as raw materials and human operators\, are taken into consideration. \nThis concern is critical in advanced products/therapeutics facilities where often distinct areas within manufacturing are slowly merging\, providing potential new sites for contamination events. The conference showcases sessions that cover alternative endotoxin testing and rapid mycoplasma testing as well as implementation of in-line biodurden monitoring to control water systems\, to name a few. Due to the complexities brought about by more advanced therapeutic products\, both drugs and patients are time dependent and rapid methods are ever more desired. \nA significant portion of the conference will focus on contamination control strategies and facilities support/novel technologies such as a look at a sustainable global contamination control program\, cleanroom pass thru best practices and a case study executing rapid transition from clinical to commercial manufacturing and more. Also see a regulatory session discussing objectionable organisms in non-sterile drug products and an all-women panel discussion: ‘culturing’ successful women microbiologists. \nEvent Hashtag: #SMiPharmaMicroWC \nKEY HIGHLIGHTS FOR 2021 INCLUDE: \n\nDiscuss the guidance\, regulations and case studies for objectionable organisms in non-sterile drug products from ValSource\, Inc.\nGain insight into changing paradigms – moving to in-process testing from Johnson & Johnson\nExamine alternative endotoxin test methods for products exhibiting LER from Amgen\nExplore how to effectively scale up from clinical to commercial in three moves from Bristol-Myers Squibb\nJoin us for our first All-Women Panel Discussion on ‘Culturing’ successful women microbiologists\n\nPlus a half day interactive workshop on Wednesday\, June 16th 2021: \nAfternoon Workshop: Data Integrity in Environmental Monitoring: Causes and Solutions \nLed by: Ziva Abraham\, CEO\, Microrite and Morgan Polen\, SME\, Cleanroom Contamination Control Expert\, Microrite \nView the full agenda: http://www.pharma-microbiology-usa.com \nWHO SHOULD ATTEND \nSenior Microbiologist\, Lead Scientist\, Laboratory Manager\, QA Specialist Drug Substance External Manufacturer\, Business Development Manager – Testing\, Pharmaceutical Microbiology Consultant\, Higher Pharmacopoeia Scientist\, Analytical Standards Specialist \nSOCIAL MEDIA HANDLES \nTwitter: @SMiPharm\nEvent Hashtag: #SMiPharmaMicroWC\nLinkedIn: follow our company page – search ‘SMi Pharma’ \nADDITIONAL CONTACT INFO\nSimi Sapal – Marketing Manager\nPharmaceutical Division – SMi Group Ltd\nT: +44 (0)20 7827 6100\nE: ssapal@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/pharmaceutical-microbiology-west-coast/
LOCATION:Hyatt Regency Mission Bay Hotel\, 1441 Quivira Road\, San Diego\, CA\, CA 92109\, United States
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210617
DTEND;VALUE=DATE:20210618
DTSTAMP:20260515T190342
CREATED:20210617T072629Z
LAST-MODIFIED:20210617T072629Z
UID:30572-1623888000-1623974399@www.pharmajournalist.com
SUMMARY:6th Annual Oncolytic Virotherapy Summit
DESCRIPTION:In its most exciting year yet the field of oncolytic virotherapy has seen the highest number of clinical read-outs\, the emergence of next generation viruses\, and never-before-seen combination therapies. \nNow in its 6th year\, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 days of in-depth cutting-edge case studies and the highest caliber of industry discussions\, The OV Summit will provide the roadmap to oncolytic virotherapy market success. \n \nUncover fresh studies from pharma and biotech companies of all sizes\, as well as clinicians and leading academics for a complete picture of the current challenges and opportunities. \nThis year’s Summit will help you to: \n\nUnderstand how viral backbone modification can achieve intravenous delivery\nHarness carefully selected payloads to achieve systemic effects\nScale virus production for commercialization\nThis year\, over 100+ drug developers will converge at the OV Summit to disseminate the latest findings\, build a comprehensive network of like-minded peers who share the same challenges and search for the latest combination and genetic engineering strategies.\n\nJoin the leading minds in oncolytic virus development to optimize the development of viral immunotherapies and improve patient outcomes in combination therapies.
URL:https://www.pharmajournalist.com/event/6th-annual-oncolytic-virotherapy-summit/
LOCATION:Westin Copley Place\, 10 Huntington Ave\, Boston\, MA\, MA 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR